Cargando…
Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
Pituitary apoplexy is a rare clinical presentation caused by infarction of the pituitary gland or adenoma with or without hemorrhage. Although pituitary apoplexy is usually spontaneous, one of the predisposing factors is treatment with dopamine agonists, especially bromocriptine. The occurrence of a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820907/ https://www.ncbi.nlm.nih.gov/pubmed/29492132 http://dx.doi.org/10.4103/1793-5482.181130 |
_version_ | 1783301455983149056 |
---|---|
author | Ghadirian, Hesam Shirani, Mohamad Ghazi-Mirsaeed, Shahab Mohebi, Saleh Alimohamadi, Maysam |
author_facet | Ghadirian, Hesam Shirani, Mohamad Ghazi-Mirsaeed, Shahab Mohebi, Saleh Alimohamadi, Maysam |
author_sort | Ghadirian, Hesam |
collection | PubMed |
description | Pituitary apoplexy is a rare clinical presentation caused by infarction of the pituitary gland or adenoma with or without hemorrhage. Although pituitary apoplexy is usually spontaneous, one of the predisposing factors is treatment with dopamine agonists, especially bromocriptine. The occurrence of apoplexy during cabergoline therapy is reported much less frequently. In this article, we report a 34-year-old man with macroprolactinomas who developed sudden visual deterioration due to pituitary apoplexy 1 year after initiation of cabergoline therapy. He was treated via endoscopic trans-sphenoidal surgery and his visual status recovered dramatically. |
format | Online Article Text |
id | pubmed-5820907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-58209072018-02-28 Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline Ghadirian, Hesam Shirani, Mohamad Ghazi-Mirsaeed, Shahab Mohebi, Saleh Alimohamadi, Maysam Asian J Neurosurg Case Report Pituitary apoplexy is a rare clinical presentation caused by infarction of the pituitary gland or adenoma with or without hemorrhage. Although pituitary apoplexy is usually spontaneous, one of the predisposing factors is treatment with dopamine agonists, especially bromocriptine. The occurrence of apoplexy during cabergoline therapy is reported much less frequently. In this article, we report a 34-year-old man with macroprolactinomas who developed sudden visual deterioration due to pituitary apoplexy 1 year after initiation of cabergoline therapy. He was treated via endoscopic trans-sphenoidal surgery and his visual status recovered dramatically. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5820907/ /pubmed/29492132 http://dx.doi.org/10.4103/1793-5482.181130 Text en Copyright: © 2018 Asian Journal of Neurosurgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Ghadirian, Hesam Shirani, Mohamad Ghazi-Mirsaeed, Shahab Mohebi, Saleh Alimohamadi, Maysam Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title | Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title_full | Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title_fullStr | Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title_full_unstemmed | Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title_short | Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline |
title_sort | pituitary apoplexy during treatment of prolactinoma with cabergoline |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820907/ https://www.ncbi.nlm.nih.gov/pubmed/29492132 http://dx.doi.org/10.4103/1793-5482.181130 |
work_keys_str_mv | AT ghadirianhesam pituitaryapoplexyduringtreatmentofprolactinomawithcabergoline AT shiranimohamad pituitaryapoplexyduringtreatmentofprolactinomawithcabergoline AT ghazimirsaeedshahab pituitaryapoplexyduringtreatmentofprolactinomawithcabergoline AT mohebisaleh pituitaryapoplexyduringtreatmentofprolactinomawithcabergoline AT alimohamadimaysam pituitaryapoplexyduringtreatmentofprolactinomawithcabergoline |